Streetbeat News

Earnings

CAPR

Capricor Therapeutics (NASDAQ:CAPR) reported a narrower Q3 loss of $(0.25) per share compared to $(0.26) last year, with sales of $6.18M significantly exceeding the $2.11M estimate, marking a 288.51% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:11 pm

GETY

Getty Images has reduced its revenue guidance for 2023 from the previously estimated range of $920M-$935M to a new range of $900M-$910M, which is below the analyst consensus estimate of $926.88M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:09 pm

GETY

Getty Images reported a Q3 EPS of $(0.05), missing earnings expectations, with revenue of $229.3M slightly above the estimate of $228.137M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:08 pm

QUIK

QuickLogic (NASDAQ:QUIK) reported Q3 adjusted earnings of $0.13 per share, missing the consensus estimate of $0.14 by 7.14%. However, sales of $6.67M exceeded estimates of $6.50M by 2.54%, marking a 92.69% increase from the same period last year. Last year's Q3 saw losses of $(0.07) per share.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:08 pm

LOWLF

Lowell Farms Inc (OTCQX:LOWLF), a cannabis company, reported a 28% decrease in Q3 revenue to $6.2 million and a net loss of $20.2 million, compared to a $4.8 million loss in Q3 2022. Despite the revenue drop and increased net loss, the company has reduced its debt and is optimistic about its restructuring strategy. Shares of LOWLF were down 11.01% to $0.24 per share.

Portfolio Pulse from Patricio Liddle

November 14, 2023 | 9:08 pm

VTSI

VirTra reported a Q3 EPS of $0.15 and a total revenue of $7.6M, which is a 54% increase compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:06 pm

HRTX

Heron Therapeutics (NASDAQ:HRTX) reported Q3 earnings with an EPS of $(0.17), surpassing the $(0.29) estimate, marking a 55.26% improvement from last year. However, sales of $31.43M fell short of the $32.75M estimate, despite being 18.36% higher than the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:06 pm

ARMP

Armata Pharmaceuticals (AMEX:ARMP) reported a Q3 EPS loss of $(0.86), significantly missing the $(0.31) estimate, representing a 258.33% increase in losses year-over-year. However, sales of $1.23M exceeded expectations by 28.95%, despite being an 8.45% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:05 pm

BEAT

HeartBeam (NASDAQ:BEAT) reported a narrower loss of $(0.13) per share in Q3, improving from a loss of $(0.44) per share in the same quarter last year, indicating a 70.45% increase in earnings.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:05 pm

DNMR

Danimer Scientific (NYSE:DNMR) reported a Q3 EPS loss of $(0.39), an improvement from $(0.94) last year, but missed sales estimates with $10.95M compared to the expected $14.74M. Sales increased by 4.79% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:03 pm